drugset / Trial / NCT07527650
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.
Timeline
- Start
- 2026-05-18
- Primary completion
- 2027-10
- Completion
- 2027-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HM15275 | Unknown | — | Subcutaneous |